Lemonaid Health vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Willow scores higher on our rubric, 7.5/10 against 7.2/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Embody - our featured pick →or find your match

Willow beats Lemonaid Health overall, scoring 7.5/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Lemonaid Health is published $129/mo; total not verified; Willow is from $299/mo. Choose Lemonaid Health for users who want a flexible membership with broad medication options, $49/mo platform fee + compounded ($199), microdose ($199), or brand-name zepbound via lillydirect ($299-449). Choose Willow for users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

A side-by-side look at Lemonaid Health and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Lemonaid Health

#37 of 54

7.2/10

Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).

Visit Lemonaid Health

Higher Rated

Willow

#20 of 54

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Lemonaid Health	Willow
Why each one	One of the oldest and most established telehealth brands in the GLP-1 space, over a decade of operation and physician-only prescribing standards that exceed most competitors.	One of the few compounded-only platforms offering both injectable and daily oral semaglutide tablets, useful for users who want a non-injectable option without leaving the GLP-1 compounded category.
Our Score	7.2/10	7.5/10
Headline Price	published $129/mo; total not verified	from $299/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want a flexible membership with broad medication options, $49/mo platform fee + compounded ($199), microdose ($199), or brand-name Zepbound via LillyDirect ($299-449)	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Watch out for	Membership and medication billed separately, the $49/mo number is just the membership, not all-in	Compounded-only, no brand-name Wegovy or Zepbound through the platform
Ranking	#37	#20
Get started	Visit Lemonaid Health	Visit Willow

Pros & Cons Compared

Lemonaid Health

Pros

+2026 restructure, $49/mo Weight Loss Membership (replaces the old $25/visit model)
+6-month plan discount, compounded tirzepatide drops to $229/mo on a 6-month commitment
+Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
+Established since 2013 with physician-only prescribing and rigorous intake

Cons

−Membership and medication billed separately, the $49/mo number is just the membership, not all-in
−Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high, read as access, not value
−Best compounded pricing requires a 6-month commitment
−The 23andMe acquisition created some uncertainty about the platform's long-term focus

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Lemonaid Health with a score of 7.5/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Lemonaid Health is published $129/mo; total not verified; Willow is from $299/mo. Lemonaid Health offers both brand-name and compounded medications, giving you more flexibility.